Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Analysis of 4% Chlorhexidine Versus Methylated Spirit as Prophylaxis of Omphalitis and Sepsis in Newborns

NCT06002295 is registered in ClinicalTrials.gov with Sheikh Zayed Federal Postgraduate Medical Institute as lead sponsor.

NCT NCT06002295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06002295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Analysis of 4% Chlorhexidine Versus Methylated Spirit as Prophylaxis of Omphalitis and Sepsis in Newborns
Lead sponsor
Sheikh Zayed Federal Postgraduate Medical Institute
Phase
Phase 2
Overall status
Completed
Start date
September 12, 2020
Completion date
November 19, 2021
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal sepsis, omphalitis